Jim Simons started to build up the position in Rapport Therapeutics in Q2 2025 and continued to invest until Q4 2025. Since then they sold 119k shares. The investor completely sold their stake between Q1 2026 and Q2 2026.
Avg closing price
Price range
Sold -9.7k shares
Q2 2026
Avg closing price
$36.70
Price range
$31.67
-
$41.67
Sold 91.8% shares (-109k shares)
Q1 2026
Avg closing price
$27.91
Price range
$25.55
-
$31.29
Increased shares by 236.6% (+83.5k shares)
Q4 2025
Avg closing price
$27.70
Price range
$24.37
-
$31.90
Increased shares by 126.3% (+19.7k shares)
Q3 2025